Sham Mailankody, MBBS¹, Jeffrey V. Matous, MD², Michaela Liedtke, MD³, Surbhi Sidana, MD⁴, Shahbaz Malik, MD^5*, Rajneesh Nath, MD⁶, Olalekan O. Oluwole, MBBS, MPH⁷, Erin E. Karski^8*, Wade Lovelace^8*, Xiangdong Zhou, PhD^8*, Srinand Nandakumar, PhD^8*, Arun Balakumaran, MD, PhD⁸ and Parameswaran Hari, MBBS, MD⁹

¹Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY
²Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
³Division of Hematology, Stanford University, Stanford, CA
⁴Center for Cancer Cell Therapy, Stanford University, Stanford, CA
⁵Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX
⁶Banner MD Anderson Cancer Center, Gilbert, AZ
⁷Vanderbilt Univeristy, Nashville, TN
⁸Allogene Therapeutics, South San Francisco, CA
⁹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI

Melissa Alsina, MD¹, Nina Shah, MD², Noopur S. Raje, MD³, Sundar Jagannath, MD⁴, Deepu Madduri, MD⁵, Jonathan L. Kaufman, MD⁶, David S. Siegel, MD⁷, Nikhil C. Munshi, MD⁸, Jacalyn Rosenblatt, MD⁹, Yi Lin, MD, PhD¹⁰, Andrzej Jakubowiak, MD, PhD¹¹, Jagoda Jasielec, MD^11*, Alison Timm, MS^12*, Ashley Turka^12*, Pingping Mao, PhD^12*, Nathan Martin, PhD^13*, Timothy B. Campbell, MD, PhD^13*, Kristen Hege¹³, Hans Bitter, PhD^12*, Fabio Petrocca, MD^12* and Jesus G. Berdeja, MD¹⁴

¹Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL
²Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
³Massachusetts General Hospital Cancer Center, Mass General Hospital Cancer Center, Boston, MA
⁴Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY
⁵Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁷Hackensack Univ. Med. Ctr., Hackensack, NJ
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹University of Chicago, Chicago, IL
¹²bluebird bio, Cambridge, MA
¹³Bristol Myers Squibb, Princeton, NJ
¹⁴Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN

Yi Lin, MD, PhD¹, Noopur S. Raje, MD², Jesus G. Berdeja, MD³, David S. Siegel, MD⁴, Sundar Jagannath, MD⁵, Deepu Madduri, MD^5*, Michaela Liedtke, MD⁶, Jacalyn Rosenblatt, MD⁷, Marcela V. Maus, MD, PhD², Monica Massaro, MPH^8*, Fabio Petrocca, MD^9*, Andrea Caia, MS^10*, Zhihong Yang, PhD^10*, Timothy B. Campbell, MD, PhD^10*, Kristen Hege, MD¹⁰, Nikhil C. Munshi, MD¹¹ and James N. Kochenderfer, MD¹²

¹Mayo Clinic, Rochester, MN
²Massachusetts General Hospital Cancer Center, Boston, MA
³Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁴Hackensack University Medical Center, Hackensack, NJ
⁵Mount Sinai Medical Center, New York, NY
⁶Stanford University Medical Center, Stanford, CA
⁷Beth Israel Deaconess Medical Center, Boston, MA
⁸bluebird bio, Inc., Cambridge, MA
⁹bluebird bio, Cambridge, MA
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Surgery Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD

Siguo Hao, MD, PhD^1*, Jie Jin, MD, PhD², Songfu Jiang, MD^3*, Zonghai Li, MD, PhD^4*, Wenhao Zhang, MD, PhD^1*, Min Yang, MD, PhD^5*, Kang Yu, MD^3*, Wei Wang, MD, PhD^4*, Linjun Chen, MD, PhD^1*, Haitao Meng, MD, PhD^5*, Mingxia He, MD^3*, Jun Xiao, MD^4*, Rong Tao, MD, PhD^1*, Xin Huang, MD, PhD^5*, Chongyun Xing, MD^3*, Daijing Yuan, MD^4*, Jianbo Wan, MD, PhD^1*, Shasha Wang, MD, PhD^5*, Lihui Dai, BS^3* and Hong Ma, MD⁶

¹Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
²Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
³The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⁴CARsgen Therapeutics Co. Ltd, Shanghai, China
⁵The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶CARsgen Therapeutics Corporation, Bellaire, TX

Shaji K. Kumar, MD¹, Rachid C. Baz, MD², Robert Z. Orlowski, MD, PhD³, Larry D. Anderson Jr., MD, PhD⁴, Hong Ma, MD⁵, Alexandria Shrewsbury, MS^2*, Katrina A. Croghan, M.S.^6*, Mrinalini Bilgi, MS^5*, Ankit Kansagra, MD⁴, Prashant Kapoor, MD¹, Zonghai Li, MD, PhD^7* and Jason Brayer, PhD, MD²

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²H. Lee Moffitt Cancer Center, Tampa, FL
³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁵CARsgen Therapeutics Corporation, Bellaire, TX
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷CARsgen Therapeutics Co. Ltd, Shanghai, China

Caitlin L. Costello, MD¹, Adam D. Cohen, MD², Krina K. Patel, M.D.³, Syed S Ali, MD⁴, Jesus G. Berdeja, MD⁵, Nina Shah, MD⁶, Siddhartha Ganguly, MD^7*, Mehmet Hakan Kocoglu, MD⁸, Mehrdad Abedi, MD⁹, Eric M. Ostertag, MD, PhD^10*, Chris E Martin, Ph.D.^10*, Majid Ghoddussi, Ph.D.^11*, Devon J Shedlock, PhD¹⁰, Joanne McCaigue, M.S.^11*, Hamid Namini, Ph.D.^11*, Sreeni Yalamanchili^11*, Matthew A. Spear, MD¹¹ and Tara K. Gregory, MD^12*

¹Moores Cancer Center, University of California, San Diego, La Jolla, CA
²University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Hematology, John Hopkins University, Baltimore, MD
⁵Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁶Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
⁷The University of Kansas Cancer Center, Fairway, KS
⁸Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁹University of California Davis, Sacramento, CA
¹⁰Poseida Therapeutics, Inc., San Diego, CA
¹¹Poseida Therapeutics, San Diego, CA
¹²Sarah Cannon Research Institute, Nashville, TN